BNTX
$109.8
Revenue | $182.8Mn |
Net Profits | $-415.8Mn |
Net Profit Margins | -227.46% |
Biontech Se’s revenue fell -2.56% since last year same period to $182.8Mn in the Q1 2025. On a quarterly growth basis, Biontech Se has generated -84.64% fall in its revenue since last 3-months.
Biontech Se’s net profit fell -31.96% since last year same period to $-415.8Mn in the Q1 2025. On a quarterly growth basis, Biontech Se has generated -260.23% fall in its net profits since last 3-months.
Biontech Se’s net profit margin fell -35.42% since last year same period to -227.46% in the Q1 2025. On a quarterly growth basis, Biontech Se has generated -1143.08% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.7 |
EPS Estimate Current Year | -1.7 |
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at -1.7 - a 27.57% jump from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at -1.7.
Earning Per Share (EPS) | 0 |
Biontech Se’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Biontech Se has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-08-04 | -1.7 | 0 | 100% |
2025-05-05 | -2.35 | -1.82 | 22.42% |